FOXO3 and Miyoshi myopathy: Moreover, when we subdivided MM samples into two groups based on FOXO3 expression, individuals with low expression (3-year OS 74.4%, 95% confidence interval: 66.1–81.0) tended to have shorter survival than those with high expression (3-year OS 82.4%, 95% confidence interval: 74.7–88.0) (Figure 3B).